GERN ▲ +0.9% - Geron Corporation
$GERN - Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis
28-OCT-2026 08:00 AM ET
Share this post
More filings for $GERN
GERN ▼ -6.1% - Geron CorporationOct 28, 2026GERN ▲ +0.9% - Geron CorporationOct 28, 2026GERN ▼ -0.8% - Geron CorporationOct 21, 2026GERN ▼ -1.5% - Geron CorporationSep 18, 2026GERN ▼ -0.7% - Geron CorporationSep 2, 2026GERN - Geron Corporation - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $GERN filing history →💬 Comments
Loading comments…
Leave a comment